Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies

Non-invasive Gamma ENtrainment Using Sensory stimulation (GENUS) at 40Hz reduces Alzheimer’s disease (AD) pathology such as amyloid and tau levels, prevents cerebral atrophy, and improves behavioral testing performance in mouse models of AD. Here, we report data from (1) a Phase 1 feasibility study...

Full description

Bibliographic Details
Main Authors: Diane Chan, Ho-Jun Suk, Brennan L. Jackson, Noah P. Milman, Danielle Stark, Elizabeth B. Klerman, Erin Kitchener, Vanesa S. Fernandez Avalos, Gabrielle de Weck, Arit Banerjee, Sara D. Beach, Joel Blanchard, Colton Stearns, Aaron D. Boes, Brandt Uitermarkt, Phillip Gander, Matthew Howard, Eliezer J. Sternberg, Alfonso Nieto-Castanon, Sheeba Anteraper, Susan Whitfield-Gabrieli, Emery N. Brown, Edward S. Boyden, Bradford C. Dickerson, Li-Huei Tsai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714926/?tool=EBI
_version_ 1811297838602125312
author Diane Chan
Ho-Jun Suk
Brennan L. Jackson
Noah P. Milman
Danielle Stark
Elizabeth B. Klerman
Erin Kitchener
Vanesa S. Fernandez Avalos
Gabrielle de Weck
Arit Banerjee
Sara D. Beach
Joel Blanchard
Colton Stearns
Aaron D. Boes
Brandt Uitermarkt
Phillip Gander
Matthew Howard
Eliezer J. Sternberg
Alfonso Nieto-Castanon
Sheeba Anteraper
Susan Whitfield-Gabrieli
Emery N. Brown
Edward S. Boyden
Bradford C. Dickerson
Li-Huei Tsai
author_facet Diane Chan
Ho-Jun Suk
Brennan L. Jackson
Noah P. Milman
Danielle Stark
Elizabeth B. Klerman
Erin Kitchener
Vanesa S. Fernandez Avalos
Gabrielle de Weck
Arit Banerjee
Sara D. Beach
Joel Blanchard
Colton Stearns
Aaron D. Boes
Brandt Uitermarkt
Phillip Gander
Matthew Howard
Eliezer J. Sternberg
Alfonso Nieto-Castanon
Sheeba Anteraper
Susan Whitfield-Gabrieli
Emery N. Brown
Edward S. Boyden
Bradford C. Dickerson
Li-Huei Tsai
author_sort Diane Chan
collection DOAJ
description Non-invasive Gamma ENtrainment Using Sensory stimulation (GENUS) at 40Hz reduces Alzheimer’s disease (AD) pathology such as amyloid and tau levels, prevents cerebral atrophy, and improves behavioral testing performance in mouse models of AD. Here, we report data from (1) a Phase 1 feasibility study (NCT04042922, ClinicalTrials.gov) in cognitively normal volunteers (n = 25), patients with mild AD dementia (n = 16), and patients with epilepsy who underwent intracranial electrode monitoring (n = 2) to assess safety and feasibility of a single brief GENUS session to induce entrainment and (2) a single-blinded, randomized, placebo-controlled Phase 2A pilot study (NCT04055376) in patients with mild probable AD dementia (n = 15) to assess safety, compliance, entrainment, and exploratory clinical outcomes after chronic daily 40Hz sensory stimulation for 3 months. Our Phase 1 study showed that 40Hz GENUS was safe and effectively induced entrainment in both cortical regions and other cortical and subcortical structures such as the hippocampus, amygdala, insula, and gyrus rectus. Our Phase 2A study demonstrated that chronic daily 40Hz light and sound GENUS was well-tolerated and that compliance was equally high in both the control and active groups, with participants equally inaccurate in guessing their group assignments prior to unblinding. Electroencephalography recordings show that our 40Hz GENUS device safely and effectively induced 40Hz entrainment in participants with mild AD dementia. After 3 months of daily stimulation, the group receiving 40Hz stimulation showed (i) lesser ventricular dilation and hippocampal atrophy, (ii) increased functional connectivity in the default mode network as well as with the medial visual network, (iii) better performance on the face-name association delayed recall test, and (iv) improved measures of daily activity rhythmicity compared to the control group. These results support further evaluation of GENUS in a pivotal clinical trial to evaluate its potential as a novel disease-modifying therapeutic for patients with AD.
first_indexed 2024-04-13T06:10:09Z
format Article
id doaj.art-c43eb432021f40a58ded16cd9e8cf551
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T06:10:09Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-c43eb432021f40a58ded16cd9e8cf5512022-12-22T02:59:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-011712Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studiesDiane ChanHo-Jun SukBrennan L. JacksonNoah P. MilmanDanielle StarkElizabeth B. KlermanErin KitchenerVanesa S. Fernandez AvalosGabrielle de WeckArit BanerjeeSara D. BeachJoel BlanchardColton StearnsAaron D. BoesBrandt UitermarktPhillip GanderMatthew HowardEliezer J. SternbergAlfonso Nieto-CastanonSheeba AnteraperSusan Whitfield-GabrieliEmery N. BrownEdward S. BoydenBradford C. DickersonLi-Huei TsaiNon-invasive Gamma ENtrainment Using Sensory stimulation (GENUS) at 40Hz reduces Alzheimer’s disease (AD) pathology such as amyloid and tau levels, prevents cerebral atrophy, and improves behavioral testing performance in mouse models of AD. Here, we report data from (1) a Phase 1 feasibility study (NCT04042922, ClinicalTrials.gov) in cognitively normal volunteers (n = 25), patients with mild AD dementia (n = 16), and patients with epilepsy who underwent intracranial electrode monitoring (n = 2) to assess safety and feasibility of a single brief GENUS session to induce entrainment and (2) a single-blinded, randomized, placebo-controlled Phase 2A pilot study (NCT04055376) in patients with mild probable AD dementia (n = 15) to assess safety, compliance, entrainment, and exploratory clinical outcomes after chronic daily 40Hz sensory stimulation for 3 months. Our Phase 1 study showed that 40Hz GENUS was safe and effectively induced entrainment in both cortical regions and other cortical and subcortical structures such as the hippocampus, amygdala, insula, and gyrus rectus. Our Phase 2A study demonstrated that chronic daily 40Hz light and sound GENUS was well-tolerated and that compliance was equally high in both the control and active groups, with participants equally inaccurate in guessing their group assignments prior to unblinding. Electroencephalography recordings show that our 40Hz GENUS device safely and effectively induced 40Hz entrainment in participants with mild AD dementia. After 3 months of daily stimulation, the group receiving 40Hz stimulation showed (i) lesser ventricular dilation and hippocampal atrophy, (ii) increased functional connectivity in the default mode network as well as with the medial visual network, (iii) better performance on the face-name association delayed recall test, and (iv) improved measures of daily activity rhythmicity compared to the control group. These results support further evaluation of GENUS in a pivotal clinical trial to evaluate its potential as a novel disease-modifying therapeutic for patients with AD.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714926/?tool=EBI
spellingShingle Diane Chan
Ho-Jun Suk
Brennan L. Jackson
Noah P. Milman
Danielle Stark
Elizabeth B. Klerman
Erin Kitchener
Vanesa S. Fernandez Avalos
Gabrielle de Weck
Arit Banerjee
Sara D. Beach
Joel Blanchard
Colton Stearns
Aaron D. Boes
Brandt Uitermarkt
Phillip Gander
Matthew Howard
Eliezer J. Sternberg
Alfonso Nieto-Castanon
Sheeba Anteraper
Susan Whitfield-Gabrieli
Emery N. Brown
Edward S. Boyden
Bradford C. Dickerson
Li-Huei Tsai
Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
PLoS ONE
title Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
title_full Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
title_fullStr Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
title_full_unstemmed Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
title_short Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
title_sort gamma frequency sensory stimulation in mild probable alzheimer s dementia patients results of feasibility and pilot studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714926/?tool=EBI
work_keys_str_mv AT dianechan gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT hojunsuk gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT brennanljackson gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT noahpmilman gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT daniellestark gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT elizabethbklerman gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT erinkitchener gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT vanesasfernandezavalos gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT gabrielledeweck gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT aritbanerjee gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT saradbeach gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT joelblanchard gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT coltonstearns gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT aarondboes gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT brandtuitermarkt gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT phillipgander gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT matthewhoward gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT eliezerjsternberg gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT alfonsonietocastanon gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT sheebaanteraper gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT susanwhitfieldgabrieli gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT emerynbrown gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT edwardsboyden gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT bradfordcdickerson gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies
AT lihueitsai gammafrequencysensorystimulationinmildprobablealzheimersdementiapatientsresultsoffeasibilityandpilotstudies